Purpose: To compare Thais' health-related quality of life (HRQOL) and severity grading, efficacy and safety in daily-life-affected benign essential blepharospasm (BEB) patients at baseline and after Botulinum toxin type A (BTX-A) treatment.
Design: Prospective-observational study.
Participants: BEB patients with Jankovic rating scale (JRS) at least 3 in both severity and frequency graded from 14 institutes nationwide were included from August 2020 to June 2021.
Background: Endovascular therapy is the first-line treatment for the cavernous sinus dural arteriovenous fistulas, particularly transvenous embolization. This study aimed to assess the trans-superior ophthalmic vein approach to embolization for its safety, efficacy, and viability as a first-line treatment in selected patients, with a description of the microsurgical and endovascular techniques.
Methods: We retrospectively reviewed patients with cavernous sinus dural arteriovenous fistulas treated using the direct superior ophthalmic vein approach with n-butyl cyanoacrylate and coils as the main embolic materials from 2015 to 2021.
Background: Pterygium may induce pressure and distortion on the corneal surface leading to ocular aberrations.
Objective: To evaluate higher order aberrations in pterygium eyes.
Material And Method: Thirty-two patients with unilateral primary pterygium were enrolled.
The purpose of this study was to compare central laminar thickness (LT) among patients with glaucomatous optic neuropathy (GON), patients with non-GON, and normal subjects using enhanced-depth imaging optical coherence tomography (EDI-OCT). Enrolled were 57 patients ( = 64 eyes), including 30 women and 27 men. Three groups were identified: GON ( = 18 eyes), non-GON ( = 16 eyes), and control ( = 30 eyes).
View Article and Find Full Text PDF